These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25588886)

  • 1. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterohaemorrhagic Escherichia coli serogroup O111 inhibits NF-(kappa)B-dependent innate responses in a manner independent of a type III secreted OspG orthologue.
    Nobe R; Nougayrède JP; Taieb F; Bardiau M; Cassart D; Navarro-Garcia F; Mainil J; Hayashi T; Oswald E
    Microbiology (Reading); 2009 Oct; 155(Pt 10):3214-3225. PubMed ID: 19628559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.
    Jayamani E; Mylonakis E
    Virulence; 2014; 5(7):733-9. PubMed ID: 25513774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.
    Yen H; Sugimoto N; Tobe T
    PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Host Cell Processes by T3SS Effectors.
    Shenoy AR; Furniss RCD; Goddard PJ; Clements A
    Curr Top Microbiol Immunol; 2018; 416():73-115. PubMed ID: 30178263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Ugalde-Silva P; Gonzalez-Lugo O; Navarro-Garcia F
    Front Cell Infect Microbiol; 2016; 6():87. PubMed ID: 27606286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell death response to enteropathogenic Escherichia coli infection.
    Wong Fok Lung T; Pearson JS; Schuelein R; Hartland EL
    Cell Microbiol; 2014 Dec; 16(12):1736-45. PubMed ID: 25266336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany.
    Kozub-Witkowski E; Krause G; Frankel G; Kramer D; Appel B; Beutin L
    J Appl Microbiol; 2008 Feb; 104(2):403-10. PubMed ID: 17887989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attaching and effacing pathogens: the effector ABC of immune subversion.
    Riebisch AK; Mühlen S
    Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria.
    Katsowich N; Elbaz N; Pal RR; Mills E; Kobi S; Kahan T; Rosenshine I
    Science; 2017 Feb; 355(6326):735-739. PubMed ID: 28209897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes.
    Sanchez-Villamil J; Navarro-Garcia F
    Future Microbiol; 2015; 10(6):1009-33. PubMed ID: 26059623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
    Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
    Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli.
    Munera D; Martinez E; Varyukhina S; Mahajan A; Ayala-Sanmartin J; Frankel G
    Biochem J; 2012 Aug; 445(3):383-92. PubMed ID: 22587461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tip of the Iceberg: On the Roles of Regulatory Small RNAs in the Virulence of Enterohemorrhagic and Enteropathogenic
    Bhatt S; Egan M; Jenkins V; Muche S; El-Fenej J
    Front Cell Infect Microbiol; 2016; 6():105. PubMed ID: 27709103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.